LeadIQ logo
Learn more at LeadIQ.com
✕

Access Insights for Haima Therapeutics and Millions of Other Companies

Sign up for full access to Haima Therapeutics information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Insights

Unique Hemostatic Technology Haima Therapeutics offers a proprietary, innovative nanoparticle-based synthetic hemostatic technology called SynthoPlate designed to address bleeding disorders effectively, providing a distinctive value proposition in the biotechnology market.

Potential Collaboration with Universities Given the company's proximity to Case Western Reserve University, University Hospitals, and the Cleveland Clinic, there is a significant opportunity for collaboration on research projects or clinical trials, leveraging the academic expertise and facilities available in the region.

Funding Support and Growth With close to $1 million in funding, Haima Therapeutics has the financial backing to expand its research and development efforts, presenting an opportunity for strategic partnerships or investment opportunities to further accelerate growth.

Competitive Landscape Analysis By examining similar companies like TISSIUM and Humacyte in terms of employee size and revenue, sales professionals can identify competitive positioning and potential market gaps to tailor their sales strategy and value proposition effectively.

Similar companies to Haima Therapeutics

✕

Access Insights for Haima Therapeutics and Millions of Other Companies

Sign up for full access to Haima Therapeutics information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Haima Therapeutics Tech Stack

Haima Therapeutics uses 5 technology products and services including Squarespace, Typekit, Modernizr, and more. Explore Haima Therapeutics's tech stack below.

  • Squarespace
    Content Management System
  • Typekit
    Font Scripts
  • Modernizr
    Javascript Libraries
  • Webpack
    Miscellaneous
  • Twitter
    Widgets

Media & News

Haima Therapeutics's Email Address Formats

Haima Therapeutics uses at least 1 format(s):
Haima Therapeutics Email FormatsExamplePercentage
FLast@haimatherapeutics.comJDoe@haimatherapeutics.com
50%
FLast@haimatherapeutics.comJDoe@haimatherapeutics.com
50%

Frequently Asked Questions

Where is Haima Therapeutics's headquarters located?

Minus sign iconPlus sign iconHaima Therapeutics's main headquarters is located at 11000 Cedar Ave Cleveland, Ohio US. The company has employees across 2 continents, including North AmericaEurope.

What is Haima Therapeutics's official website and social media links?

Minus sign iconPlus sign iconHaima Therapeutics's official website is haimatherapeutics.com and has social profiles on LinkedIn.

What is Haima Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign iconHaima Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Haima Therapeutics have currently?

Minus sign iconPlus sign iconAs of October 2024, Haima Therapeutics has approximately 13 employees across 2 continents, including North AmericaEurope. Key team members include Ceo: M. B.Co-Founder, Chief Operating Officer: C. L. P.President: F. S. F.. Explore Haima Therapeutics's employee directory with LeadIQ.

What industry does Haima Therapeutics belong to?

Minus sign iconPlus sign iconHaima Therapeutics operates in the Biotechnology Research industry.

What technology does Haima Therapeutics use?

Minus sign iconPlus sign iconHaima Therapeutics's tech stack includes SquarespaceTypekitModernizrWebpackTwitter.

What is Haima Therapeutics's email format?

Minus sign iconPlus sign iconHaima Therapeutics's email format typically follows the pattern of . Find more Haima Therapeutics email formats with LeadIQ.

How much funding has Haima Therapeutics raised to date?

Minus sign iconPlus sign icon As of October 2024, Haima Therapeutics has raised $949K in funding. The last funding round occurred on May 16, 2020 for $949K.

When was Haima Therapeutics founded?

Minus sign iconPlus sign iconHaima Therapeutics was founded in 2016.
Haima Therapeutics

Haima Therapeutics

Biotechnology ResearchOhio, United States11-50 Employees

Haima Therapeutics is a pre-clinical stage biotechnology company focused on developing bio-inspired therapies for the treatment of bleeding and other blood-related ailments. We have developed a novel, nanoparticle-based synthetic hemostatic technology, called SynthoPlate, that can staunch hemorrhagic bleeding by binding to the site of injury and amplifying your body’s natural clotting mechanisms.

Haima Therapeutics and Case Western Reserve University entered into an option to license agreement in April of 2018. Haima Therapeutics is located at the BioEnterprise incubator centrally located in the University Circle area near Case Western Reserve University, University Hospitals, and the Cleveland Clinic.

✕

Access Insights for Haima Therapeutics and Millions of Other Companies

Sign up for full access to Haima Therapeutics information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Section iconCompany Overview

Headquarters
11000 Cedar Ave Cleveland, Ohio US
Website
haimatherapeutics.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2016
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $949K

    Haima Therapeutics has raised a total of $949K of funding over 5 rounds. Their latest funding round was raised on May 16, 2020 in the amount of $949K.

Section iconFunding & Financials

  • $949K

    Haima Therapeutics has raised a total of $949K of funding over 5 rounds. Their latest funding round was raised on May 16, 2020 in the amount of $949K.

Company Leadership

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

✕

Access Insights for Haima Therapeutics and Millions of Other Companies

Sign up for full access to Haima Therapeutics information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.